INSIGHTS ON PHARMACEUTICAL PACKAGING

• Low Temperature Storage Containment For Vial And Syringe Systems

  With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.

• Integration Of Container Closure Integrity In Contract Manufacturing

  Maintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Learn how to fortify your processes.

• Innovation For Subcutaneous Delivery Of Large-Volume Complex Biologics

  Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.

• FAQs On The Revised EU GMP Annex 1: Volume 2

  Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.

• Alba® Syringe Platform: Ensuring Stability For Sensitive Drugs

  1/13/2025

  Check out this exciting video showcasing the key advantages of Alba®: innovative coating technology that reduces potential interaction between the drug and container surface.

• Single Unit Dose Nasal Spray Carton Provides Cost Savings

  8/1/2024

  Gain insight into how switching to a single-unit dose nasal sprayer carton reduced one company's material costs and significantly improved environmental sustainability throughout the product lifecycle.

• Establishing And Safeguarding Shelf Life In Combination Products

  10/27/2025

  Establishing combination product shelf life requires aligning stability. Holistic, data-driven stability studies ensure product function, safety, and label claims through the entire supply chain.

• A Robust Extractables Data Package Helps Drive Patient Safety

  10/1/2024

  Complex drug product formulations are more common, so it is imperative to have a deeper knowledge of extractables to understand risks associated with potential interactions between packaging and product.

• The Rising Need For Flexibility In Blister Packaging For CDMOs And Drug Manufacturers

  8/1/2024

  In the pharmaceutical industry, processes are subject to continuous change due to evolving requirements and regulations. Consequently, pharmaceutical companies and contract packagers often require adaptable packaging solutions, such as blister machines, to meet these dynamic needs.